NRIX · ISSUER CIK 1549595
Nurix Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 Nurix Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $1.6M of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 8 of 9 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.6MInsider selling
−$1.6MNet open-market
Oct 15, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 202617:00 | Oct 15, 2026 | NRIX | Chief Scientific Officer | S · Sell10b5-1 | $25.00 | −1,452 | 117,227 | -1% | −$36K | ||
| Oct 15, 202617:00 | Oct 15, 2026 | NRIX | Chief Scientific Officer | M · Exercise10b5-1 | $1.86 | +1,452 | 118,679 | +1% | $3K | ||
| Oct 14, 202616:11 | Oct 14, 2026 | NRIX | Director | S · Sell | $23.40 | −22,583 | 10,750 | -68% | −$529K | ||
| Oct 14, 202616:11 | Oct 14, 2026 | NRIX | Director | M · Exercise | $1.86 | +22,583 | 33,333 | +210% | $42K | ||
| Oct 2, 202617:21 | Oct 2, 2026 | NRIX | Chief Legal Officer | S · Sell10b5-1 | $23.19 | −5,786 | 9,110 | -39% | −$134K | ||
| Oct 2, 202617:21 | Oct 2, 2026 | NRIX | Chief Legal Officer | M · Exercise10b5-1 | $8.72 | +5,786 | 14,896 | +64% | $50K | ||
| Sep 2, 202619:42 | Sep 2, 2026 | NRIX | Chief Legal Officer | S · Sell10b5-1 | $25.76 | −5,787 | 9,110 | -39% | −$149K | ||
| Sep 2, 202619:42 | Sep 2, 2026 | NRIX | Chief Legal Officer | M · Exercise10b5-1 | $8.72 | +5,787 | 14,897 | +64% | $50K | ||
| Sep 1, 202617:19 | Sep 1, 2026 | NRIX | Chief Scientific Officer | S · Sell10b5-1 | $25.47 | −1,452 | 117,227 | -1% | −$37K | ||
| Sep 1, 202617:19 | Sep 1, 2026 | NRIX | Chief Scientific Officer | M · Exercise10b5-1 | $1.86 | +1,452 | 118,679 | +1% | $3K | ||
| Aug 5, 202618:59 | Aug 5, 2026 | NRIX | Chief Scientific Officer | S · Sell10b5-1 | $25.00 | −4,356 | 117,227 | -4% | −$109K | ||
| Aug 5, 202618:59 | Aug 5, 2026 | NRIX | Chief Scientific Officer | M · Exercise10b5-1 | $1.86 | +4,356 | 121,583 | +4% | $8K | ||
| Aug 5, 202606:39 | Aug 4, 2026 | NRIX | Chief Scientific Officer | S · Sell10b5-1 | $24.36 | −4,111 | 117,227 | -3% | −$100K | ||
| Aug 4, 202621:41 | Aug 4, 2026 | NRIX | Chief Financial Officer | S · Sell10b5-1 | $24.36 | −4,761 | 40,166 | -11% | −$116K | ||
| Aug 3, 202617:51 | Aug 3, 2026 | NRIX | Chief Legal Officer | S · Sell10b5-1 | $23.05 | −16,589 | 9,110 | -65% | −$382K | ||
| Aug 3, 202617:51 | Aug 3, 2026 | NRIX | Chief Legal Officer | M · Exercise10b5-1 | $8.72 | +5,787 | 25,699 | +29% | $50K |